When was IntegriChain founded?

IntegriChain was founded in 2005 and raised its 1st funding round 1 year after it was founded.

Where is IntegriChain located?

IntegriChain is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania.

How many employees does IntegriChain have?

As of Jul 31, 2026, the latest employee count at IntegriChain is 717.

Is IntegriChain a funded company?

IntegriChain is a funded company, having raised a total of $2M across 4 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Oct 11, 2006.

When was the latest funding round of IntegriChain?

IntegriChain's latest funding was a $***** PE round on Mar 01, 2016, with participation from 1 investor. Its primary sector is Biopharma Outsourcing. In United States, the Biopharma Outsourcing sector has seen $678M in funding in 2026 to date.

Where does IntegriChain rank among its competitors?

IntegriChain ranks 3rd amongst 1417 active competitors, of which 27 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Prescient Healthcare Group, which secured $18.3K in Jun, 2024.

Who are the top competitors of IntegriChain?

IntegriChain's top competitors include Clinigen, CMIC HOLDINGS and Fishawack. Among them, Prescient Healthcare Group secured the most recent funding round in June, 2024.

IntegriChain - 2026 Company Profile, Team, Funding & Competitors

IntegriChain is an acquired company based in Philadelphia (United States), founded in 2005. It operates as a Pharma commercialization solutions: data, consulting, and technology for market access. IntegriChain has raised $2M in funding from Activate Venture Partners. The company has 1417 active competitors, including 27 funded and 149 that have exited. Its top competitors include companies like Clinigen, CMIC HOLDINGS and Fishawack.

Company Details

Pharma commercialization solutions: data, consulting, and technology for market access. The company offers a comprehensive suite of services and a platform designed to address the complexities of drug commercialization. It provides strategy, data, applications, and infrastructure for therapy commercialization, focusing on optimizing price and demand through integrated commercial and net revenue analytics. The company delivers solutions for net revenue management, commercial data, and insights, helping pharmaceutical manufacturers bring their science to market. Its offerings include consulting and advisory services, regulatory compliance, market access strategy, and data and technology solutions. The company empowers pharma companies to build efficient access, affordability, and distribution strategies, maximizing net revenue. It unifies critical business functions like contracts & pricing, gross-to-net, channel, and patient services to unlock strategic insights. The platform supports data visualization, AI enablement, and data management services. It is a B2B company offering SaaS and software solutions.

Website: www.integrichain.com/
Social
Registered Address: Philadelphia, Pennsylvania

Key Metrics

Founded Year

2005

Location

Philadelphia, United States

Stage

Acquired

Total Funding

$2M in 4 rounds

Latest Funding Round

PE, Mar 01, 2016, $*****

Investors

Activate Venture Partners & 5 more

Ranked

3^rd among 1417 active competitors

Employee Count

717 as on Jul 31, 2026

Investment & Acquisitions

Federal Compliance Solutions & 3 more

Similar Companies

Clinigen & 1676 more

Exit Details

Acquired by Nordic Capital (Nov 08, 2023)

View IntegriChain's full profile

IntegriChain is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
INTEGRICHAIN, INC. CIN: 542187446 , United States, Active	Dec 31, 1999	-	396 (As on Dec 31, 2024)	-
INTEGRICHAIN PRIVATE LIMITED CIN: U72200PN2011PTC139750 , India, Active	Jun 06, 2011	₹50 - ₹100 Cr (As on Mar 31, 2025)	297 (As on Mar 31, 2024)

IntegriChain got acquired by Nordic Capital on Nov 08, 2023.

Click here to take a look at IntegriChain's acquisition in detail

IntegriChain has raised a total funding of $2M over 4 rounds. Its first funding round was on Oct 11, 2006. Its latest funding round was a PE round on Mar 01, 2016 for $*****. 1 investor participated in its latest round. IntegriChain has 6 institutional investors.

Here is the list of recent funding rounds of IntegriChain:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 01, 2016	5776183	PE	6590395	2818660	1735884	3933925
Sep 22, 2015	8817903	Venture Debt	6830417	9165683	3492397	SaaS Capital
Jul 15, 2009	9321385	Series B	4361311	4140530	Activate Venture Partners	Cross Atlantic Capital Partners

Access funding benchmarks and valuations. Sign up today!

View details of IntegriChain's funding rounds and investors

IntegriChain's employee count trend

IntegriChain has 717 employees as of Jul 26. Here is IntegriChain's employee count trend over the years:

Uncover IntegriChain's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of IntegriChain include Clinigen, CMIC HOLDINGS and Fishawack. Here is the list of Top 10 competitors of IntegriChain, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Clinigen 2010, Burton-on-trent (United Kingdom), Acquired	Services in clinical trials & medicine supply	-	RBS Group, Santander Bank & 3 others	59/100
2nd	CMIC HOLDINGS 1985, Tokyo (Japan), Acquired	Contract service provider for biopharma companies	-	-	58/100
3rd	IntegriChain 2005, Philadelphia (United States), Acquired	Pharma commercialization solutions: data, consulting, and technology for market access	$2M	SaaS Capital, Activate Venture Partners & 4 others	58/100
4th	Fishawack 2001, Brighton (United Kingdom), Acquired	Provider of fully-integrated, cross-border services to global pharmaceutical organisations	$23.6M	-	57/100
5th	Prescient Healthcare Group 2007, London (United Kingdom), Series B	Consulting services for product strategy and decision support	$12.7M	Baird Capital, Intertrust & 8 others	56/100
6th	Fabtech 2002, Mumbai (India), Public	Provider of instruments for biotech, pharmaceutical, and biomedical industries	$175K	Acaciaa International TR LLC, T Square Enterprises ... & 9 others	56/100
7th	Diaceutics 2005, Belfast (United Kingdom), Public	Analytics based integrator for precision medicine	-	Herald Investment Management, SVB & 4 others	55/100
8th	Science Group 1986, Cambridge (United Kingdom), Public	Provider of product development, regulatory, and advisory services alongside the design and manufacture of systems for the defence and audio sectors	-	Herald Investment Management	49/100
9th	Sequence 2002, Morrisville (United States), Acquired	Consulting services provider	-	-	49/100
10th	Oxford PharmaGenesis 1998, Oxford (United Kingdom), Acquired	Provider of medical affairs, marketing, communication, consultancy, and other services for healthcare sector	-	-	48/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on IntegriChain's competitors? Click here to see the top ones

IntegriChain has not made any investments yet. IntegriChain has made 4 acquisitions.

Here is the list of latest three $acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Jul 10, 2024	Acquisition	Federal Compliance Solutions	2017	Philadelphia (United States)
Jan 20, 2022	Acquisition	Blue Fin Group	2001	New York City (United States)
Feb 01, 2018	Acquisition	Medical Communication Technologies	2000	Acworth (United States)